Krystal Biotech Inc. (KRYS)
Market Closed
16 Oct, 08:00 PM
$
316. 58
-13.42
-4.0667%
$
9.78B Market Cap
- P/E Ratio
- Div Yield
226,200 Volume
- Eps
$ 330
Previous Close 
Want to track KRYS and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Krystal Biotech Inc. (KRYS) Statistics
Valuation metrics
Market Cap 9.78B
Enterprise value 9.36B
Trailing P/E (ttm) 40.1
Forward P/E -
PEG ratio 0.65
Price/Sales (ttm) 22.19
Price/Book (mrq) 7.2
Enterprise Value/Revenue 21.24
Enterprise Value/EBITDA 42.53
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 196.9K
Average volume (90 days) 321.49K
Price summary
52-Week low 183.03
52-Week high 382.54
Beta -
50-Day moving average 345.13
200-Day moving average 289.55
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.55%
Operating margin 0.45%
Operational effectiveness
Return on assets 0.16%
Return on equity 0.19%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 14.92
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 8.18
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 28.64
Total debt (mrq) -
Total Debt/Equity (mrq) 0.01
Current ratio (mrq) 8.32%
Book value per share (mrq) 46.03
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
